Molecular formula: C43H67N11O12S2
Molecular weight: 994. 19 g·mol−1
Patent period: —
Dositive specifications: –
Injection : –
Oral tablets: —
Injection: —
Molecular formula: C43H67N11O12S2
Molecular weight: 994. 19 g·mol−1
Patent period: —
Dositive specifications: –
Injection : –
Oral tablets: —
Injection: —
Atosiban is a peptide Oxytocin Receptor Inhibitor. Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra) . Atosiban inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane. As a result, reduced release of intracellular, stored calcium from the sarcoplasmic reticulum of myometrial cells and reduced influx of Ca2+ from the extracellular space through voltage-gated channels occur. In addition, atosiban suppresses oxytocin-mediated release of PGE and PGF from the decidua.
| Catalog Num | A14334 |
|---|---|
| CAS NO. | 90779-69-4 |
| FORMULA | C43H67N11O12S2 |
| M. WT | 994. 2 |
| PURITY | — |
| SMILES | CC[C@H] (C) [C@H]1C (=O) N[C@H] (C (=O) N[C@H] (C (=O) N[C@@H] (CSSCCC (=O) N[C@@H] (C (=O) N1) CC2=CC=C (C=C2) OCC) C (=O) N3CCC[C@H]3C (=O) N[C@@H] (CCCN) C (=O) NCC (=O) N) CC (=O) N) [C@@H] (C) O |
| STORAGE | Store lyophilized at -20ºC, keep desiccated. In lyophilized form, the chemical is stable for 36 months. In solution, store at -20ºC and use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles. |
Mobile:+86-1908 2363 133
E-mail:simonzhu@glptide.com
Website: www.glptide.com
